| Columbia Montour Home Hospice 410 Glenn Ave Suite 200, Bloomsburg, PA, 17815 | |
| (570) 784-1723 |
News Archive
The Pediatric Heart Center at Tulane Hospital for Children has opened the first and only Hybrid Cath Lab in Louisiana. The cutting-edge facility - one of only 10 in the country - is a fully equipped pediatric catheterization lab and operating room that allows both cardiologists and surgeons to work side by side to open the chest, place delivery catheters in the heart and deploy devices. Outcomes are improved by avoiding cardiopulmonary bypass and shortened procedure times.
BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the achievement of a clinical milestone in the company's collaboration with Merck Serono, the biopharmaceutical division of Merck, Darmstadt, Germany, for BGB-283, a second-generation BRAF inhibitor candidate currently in Phase 1 development.
The Max Planck Society (Max-Planck-Gesellschaft), Germany's leading basic research organization, announced today that it has signed with Fovea Pharmaceuticals, the Ophthalmology Division of Sanofi, a research collaboration and license agreement to identify and develop innovative solutions for restoring vision in patients suffering from diseases affecting the retina.
New York named its health exchange, complete with new logo and ad. In Idaho, the GOP governor, a vocal opponent of the health law, lauds his state's insurance marketplace. Meanwhile, Florida officials express concerns about the federal exchange's "navigator" concept.
› Verified 5 days ago
| Name | Columbia Montour Home Hospice |
|---|---|
| Location | 410 Glenn Ave Suite 200, Bloomsburg, Pennsylvania |
| Hospice ID | 391533 |
| Category | Part of a Home Health Agency |
| Ownership Type | Voluntary Non-profit - Other |
| Profit Type | NON-PROFIT |
| SSA county code | 250 |
News Archive
The Pediatric Heart Center at Tulane Hospital for Children has opened the first and only Hybrid Cath Lab in Louisiana. The cutting-edge facility - one of only 10 in the country - is a fully equipped pediatric catheterization lab and operating room that allows both cardiologists and surgeons to work side by side to open the chest, place delivery catheters in the heart and deploy devices. Outcomes are improved by avoiding cardiopulmonary bypass and shortened procedure times.
BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the achievement of a clinical milestone in the company's collaboration with Merck Serono, the biopharmaceutical division of Merck, Darmstadt, Germany, for BGB-283, a second-generation BRAF inhibitor candidate currently in Phase 1 development.
The Max Planck Society (Max-Planck-Gesellschaft), Germany's leading basic research organization, announced today that it has signed with Fovea Pharmaceuticals, the Ophthalmology Division of Sanofi, a research collaboration and license agreement to identify and develop innovative solutions for restoring vision in patients suffering from diseases affecting the retina.
New York named its health exchange, complete with new logo and ad. In Idaho, the GOP governor, a vocal opponent of the health law, lauds his state's insurance marketplace. Meanwhile, Florida officials express concerns about the federal exchange's "navigator" concept.
› Verified 5 days ago
| NPI Number | 1346280609 |
| Organization Name | Geisinger Community Health Services |
| Address | 109 Woodbine Ln Danville, Pennsylvania, 17821 |
| Phone Number | (570)271-5336 |
News Archive
The Pediatric Heart Center at Tulane Hospital for Children has opened the first and only Hybrid Cath Lab in Louisiana. The cutting-edge facility - one of only 10 in the country - is a fully equipped pediatric catheterization lab and operating room that allows both cardiologists and surgeons to work side by side to open the chest, place delivery catheters in the heart and deploy devices. Outcomes are improved by avoiding cardiopulmonary bypass and shortened procedure times.
BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the achievement of a clinical milestone in the company's collaboration with Merck Serono, the biopharmaceutical division of Merck, Darmstadt, Germany, for BGB-283, a second-generation BRAF inhibitor candidate currently in Phase 1 development.
The Max Planck Society (Max-Planck-Gesellschaft), Germany's leading basic research organization, announced today that it has signed with Fovea Pharmaceuticals, the Ophthalmology Division of Sanofi, a research collaboration and license agreement to identify and develop innovative solutions for restoring vision in patients suffering from diseases affecting the retina.
New York named its health exchange, complete with new logo and ad. In Idaho, the GOP governor, a vocal opponent of the health law, lauds his state's insurance marketplace. Meanwhile, Florida officials express concerns about the federal exchange's "navigator" concept.
› Verified 5 days ago
| NPI Number | 1467866863 |
| Organization Name | Geisinger Community Health Services |
| Address | 100 N Academy Ave Danville, Pennsylvania, 17822 |
| Phone Number | (570)784-1723 |
News Archive
The Pediatric Heart Center at Tulane Hospital for Children has opened the first and only Hybrid Cath Lab in Louisiana. The cutting-edge facility - one of only 10 in the country - is a fully equipped pediatric catheterization lab and operating room that allows both cardiologists and surgeons to work side by side to open the chest, place delivery catheters in the heart and deploy devices. Outcomes are improved by avoiding cardiopulmonary bypass and shortened procedure times.
BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the achievement of a clinical milestone in the company's collaboration with Merck Serono, the biopharmaceutical division of Merck, Darmstadt, Germany, for BGB-283, a second-generation BRAF inhibitor candidate currently in Phase 1 development.
The Max Planck Society (Max-Planck-Gesellschaft), Germany's leading basic research organization, announced today that it has signed with Fovea Pharmaceuticals, the Ophthalmology Division of Sanofi, a research collaboration and license agreement to identify and develop innovative solutions for restoring vision in patients suffering from diseases affecting the retina.
New York named its health exchange, complete with new logo and ad. In Idaho, the GOP governor, a vocal opponent of the health law, lauds his state's insurance marketplace. Meanwhile, Florida officials express concerns about the federal exchange's "navigator" concept.
› Verified 5 days ago
| NPI Number | 1477559276 |
| Organization Name | Geisinger Community Health Services |
| Address | 410 Glenn Ave Bloomsburg, Pennsylvania, 17815 |
| Phone Number | (570)784-1723 |
News Archive
The Pediatric Heart Center at Tulane Hospital for Children has opened the first and only Hybrid Cath Lab in Louisiana. The cutting-edge facility - one of only 10 in the country - is a fully equipped pediatric catheterization lab and operating room that allows both cardiologists and surgeons to work side by side to open the chest, place delivery catheters in the heart and deploy devices. Outcomes are improved by avoiding cardiopulmonary bypass and shortened procedure times.
BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the achievement of a clinical milestone in the company's collaboration with Merck Serono, the biopharmaceutical division of Merck, Darmstadt, Germany, for BGB-283, a second-generation BRAF inhibitor candidate currently in Phase 1 development.
The Max Planck Society (Max-Planck-Gesellschaft), Germany's leading basic research organization, announced today that it has signed with Fovea Pharmaceuticals, the Ophthalmology Division of Sanofi, a research collaboration and license agreement to identify and develop innovative solutions for restoring vision in patients suffering from diseases affecting the retina.
New York named its health exchange, complete with new logo and ad. In Idaho, the GOP governor, a vocal opponent of the health law, lauds his state's insurance marketplace. Meanwhile, Florida officials express concerns about the federal exchange's "navigator" concept.
› Verified 5 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.5 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.5 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 96.1 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 83.7 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.0 | 97.3 |
| Patients who got timely treatment for shortness of breath | 98.1 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 95.1 | 93.3 |
News Archive
The Pediatric Heart Center at Tulane Hospital for Children has opened the first and only Hybrid Cath Lab in Louisiana. The cutting-edge facility - one of only 10 in the country - is a fully equipped pediatric catheterization lab and operating room that allows both cardiologists and surgeons to work side by side to open the chest, place delivery catheters in the heart and deploy devices. Outcomes are improved by avoiding cardiopulmonary bypass and shortened procedure times.
BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the achievement of a clinical milestone in the company's collaboration with Merck Serono, the biopharmaceutical division of Merck, Darmstadt, Germany, for BGB-283, a second-generation BRAF inhibitor candidate currently in Phase 1 development.
The Max Planck Society (Max-Planck-Gesellschaft), Germany's leading basic research organization, announced today that it has signed with Fovea Pharmaceuticals, the Ophthalmology Division of Sanofi, a research collaboration and license agreement to identify and develop innovative solutions for restoring vision in patients suffering from diseases affecting the retina.
New York named its health exchange, complete with new logo and ad. In Idaho, the GOP governor, a vocal opponent of the health law, lauds his state's insurance marketplace. Meanwhile, Florida officials express concerns about the federal exchange's "navigator" concept.
› Verified 5 days ago
| Home Health Aides | 8.38 |
| Counselors | 1.07 |
| Licensed Practical or Vocational Nurses | 2.1 |
| Medical Social Workers | 2.91 |
| Physicians | 1 |
| Registered Nurses | 8.33 |
| Other Personnel | 5.09 |
| Total Employees | 28.88 |
|---|
News Archive
The Pediatric Heart Center at Tulane Hospital for Children has opened the first and only Hybrid Cath Lab in Louisiana. The cutting-edge facility - one of only 10 in the country - is a fully equipped pediatric catheterization lab and operating room that allows both cardiologists and surgeons to work side by side to open the chest, place delivery catheters in the heart and deploy devices. Outcomes are improved by avoiding cardiopulmonary bypass and shortened procedure times.
BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the achievement of a clinical milestone in the company's collaboration with Merck Serono, the biopharmaceutical division of Merck, Darmstadt, Germany, for BGB-283, a second-generation BRAF inhibitor candidate currently in Phase 1 development.
The Max Planck Society (Max-Planck-Gesellschaft), Germany's leading basic research organization, announced today that it has signed with Fovea Pharmaceuticals, the Ophthalmology Division of Sanofi, a research collaboration and license agreement to identify and develop innovative solutions for restoring vision in patients suffering from diseases affecting the retina.
New York named its health exchange, complete with new logo and ad. In Idaho, the GOP governor, a vocal opponent of the health law, lauds his state's insurance marketplace. Meanwhile, Florida officials express concerns about the federal exchange's "navigator" concept.
› Verified 5 days ago
| Others | 2.39 |
| Total Volunteers | 2.39 |
|---|
News Archive
The Pediatric Heart Center at Tulane Hospital for Children has opened the first and only Hybrid Cath Lab in Louisiana. The cutting-edge facility - one of only 10 in the country - is a fully equipped pediatric catheterization lab and operating room that allows both cardiologists and surgeons to work side by side to open the chest, place delivery catheters in the heart and deploy devices. Outcomes are improved by avoiding cardiopulmonary bypass and shortened procedure times.
BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the achievement of a clinical milestone in the company's collaboration with Merck Serono, the biopharmaceutical division of Merck, Darmstadt, Germany, for BGB-283, a second-generation BRAF inhibitor candidate currently in Phase 1 development.
The Max Planck Society (Max-Planck-Gesellschaft), Germany's leading basic research organization, announced today that it has signed with Fovea Pharmaceuticals, the Ophthalmology Division of Sanofi, a research collaboration and license agreement to identify and develop innovative solutions for restoring vision in patients suffering from diseases affecting the retina.
New York named its health exchange, complete with new logo and ad. In Idaho, the GOP governor, a vocal opponent of the health law, lauds his state's insurance marketplace. Meanwhile, Florida officials express concerns about the federal exchange's "navigator" concept.
› Verified 5 days ago
| Columbia Montour Home Hospice Location: 410 Glenn Ave Suite 200, Bloomsburg, Pennsylvania, 17815 Phone: (570) 784-1723 |